Drugs / COVIDEX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05228626 | Mar → Nov 2022 | COVID-19 | Makerere University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVIDEX | “COVIDEX™ Therapy” NCT05228626 ↗ |
| Known as | COVIDEXTm | “COVIDEXTm is a prepared plant extract of Zanthoxylum and Warbugia species” NCT05228626 ↗ |
| Route | Intranasal | “given either 2 drops nasally plus 6 drops orally or 6 oral drops only” NCT05228626 ↗ |
| Route | Oral | “given either 2 drops nasally plus 6 drops orally or 6 oral drops only” NCT05228626 ↗ |